Journal
EYE
Volume 24, Issue 3, Pages 416-421Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/eye.2009.306
Keywords
mice; ischaemia; retinal neovascularisation; revascularisation; hyperoxia; hypoxia
Categories
Funding
- Fight for Sight
- Biomedical Research Centre for Ophthalmology
- Moorfields Special Trustees
- Lowy Medical Research Institute LTD
- Medical Research Council
- Wellcome Trust
Ask authors/readers for more resources
Ischaemic vascular disease in the retina may either leave retina permanently ischaemic with slow degradation of vision, or alternatively lead to proliferative vascular disease, which can also destroy vision. To investigate the molecular and cellular mechanisms that contribute to this pathology a mouse model has been studied extensively. The model is based on the exposure of mouse pups to hyperoxia during a phase when their retinal vasculature is still developing. This leads to capillary depletion, and upon return to room air, results in retinal ischaemia and proliferative vascular disease in the retinal vasculature (oxygen-induced retinopathy (OIR)). Numerous studies using this OIR model have revealed that the regulation of angiogenic factors and the influence of inflammatory cells play a pivotal role in the vascular pathogenesis. It has also been demonstrated in the OIR model that proliferative vascular disease is not the only possible outcome of ischaemia-induced angiogenesis in the retina, but that ischaemic areas in the retina can be revascularised with healthy blood vessels. Therefore, understanding the factors that control the balance between pathological and healthy angiogenesis in the OIR model may have important implications for human retinal ischaemic disease. Eye (2010) 24, 416-421; doi:10.1038/eye.2009.306; published online 11 December 2009
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available